Poop pills vs. superbugs: can a stool transplant stop Drug-Resistant infections?

NCT ID NCT05981430

First seen May 14, 2026 · Last updated May 16, 2026 · Updated 1 time

Summary

This study tests whether taking capsules containing healthy donor stool (fecal microbiota transplant) can clear carbapenem-resistant Enterobacteriaceae (CRE) from the gut of hospitalized adults. CRE are hard-to-treat bacteria that can cause serious infections. The trial involves 80 patients in Hong Kong and uses a double-blind design to compare the capsules against a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FECAL MICROBIOTA TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.